SANUWAVE, Inc. Completes Investigator Meeting

Published: May 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALPHARETTA, Ga., May 13, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company held an investigator meeting in Atlanta, Georgia on May 10-11, 2013. The meeting served as the official kick-off of the supplemental Phase III clinical trial utilizing dermaPACE® for the treatment of diabetic foot ulcers. Representatives from 18 clinical sites engaged to participate in the clinical trial attended the meeting to receive training. These sites are now ready to begin screening and enrolling patients.

Help employers find you! Check out all the jobs and post your resume.

Back to news